{
    "Trade/Device Name(s)": [
        "Access TPO Antibody",
        "Access TPO Antibody Reagent on DxI 9000 Access Immunoassay Analyzer"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K240469",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061382"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JZO"
    ],
    "Summary Letter Date": "August 9, 2024",
    "Summary Letter Received Date": "February 20, 2024",
    "Submission Date": "February 16, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.5870"
    ],
    "Regulation Name(s)": [
        "Thyroid Autoantibody Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Thyroperoxidase antibody (TPOAb)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "DxI 9000 Access Immunoassay Analyzer",
        "Access Immunoassay Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Paramagnetic particle",
        "Two-step sandwich assay"
    ],
    "Methodologies": [
        "Immunoenzymatic assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Beckman Coulter Access TPO Antibody chemiluminescent immunoassay on the DxI 9000 Access Immunoassay Analyzer for quantitative determination of thyroperoxidase antibody in serum and plasma.",
    "Indications for Use Summary": "Quantitative determination of thyroperoxidase antibody (TPOAb) levels in human serum and plasma to aid in diagnosis of thyroid autoimmune disorders.",
    "fda_folder": "Immunology"
}